SiriusPoint (SPNT) Looks Cheap As Underwriting Momentum Meets A Higher Fair Value

SiriusPoint (SPNT) has been drawing fresh attention after the latest share price of $24.62, with investors reviewing its recent returns, value score of 5, and multi-line insurance and reinsurance footprint.

Recent trading has been relatively steady, with the 7-day share price return of 1.53% and year-to-date share price return of 16.85% pointing to gradually building momentum. Meanwhile, SiriusPoint’s 1-year total shareholder return of 34.46% highlights how the broader investment case has been rewarded over time.

Spot similar momentum and value traits beyond SiriusPoint by scanning our hand picked 29 high quality undervalued stocks.

SiriusPoint now trades at $24.62, while analyst targets cluster nearer $28.75 and intrinsic estimates imply an even wider gap. Is that discount pointing to underappreciated value or already fair compensation for the risks?

Most Popular Narrative: 13% Undervalued

SiriusPoint’s most followed narrative pegs fair value at $28.25, which sits above the recent $24.62 close and frames the current discount through the lens of underwriting quality and MGA growth potential rather than short term index moves.

SiriusPoint is well-positioned to benefit from rising global demand for reinsurance capacity and specialized insurance solutions amid increasing climate-driven catastrophes and the globalization of complex risks, supporting forward premium growth and higher rates, which should lift revenues and gross written premiums over time. The company is strategically allocating capital toward higher-margin specialty and casualty lines, alongside a disciplined approach to underwriting and risk selection, as evidenced by 11 consecutive quarters of underwriting profits and an improving combined ratio, suggesting a pathway to expanding net margins and earnings stability.

See why 1 investors see SiriusPoint as 13% undervalued.

That narrative uses a 7.24% discount rate and assumes earnings settle at $247.6 million by around 2029, which is below the current $494.7 million figure and reflects analyst expectations for thinner profit margins over time. To reach the implied fair value of $28.25, SiriusPoint would need the market to price those future earnings at a P/E of 16.1x compared with an industry level of 11.0x, so the story leans on the idea that today’s 5.8x multiple is too low for a business with a 22.2% return on equity and a history of improving net profit margins.

Sense check that framework against your own view on key moving pieces such as the durability of MGA partnerships, the sustainability of recent underwriting gains given climate and catastrophe risk, and whether a lower forecast return on equity of 12.3% in three years still justifies a richer multiple than the broader US insurance sector.

Result: Fair Value of $28.25 (UNDERVALUED)

Still, the narrative around SiriusPoint can shift quickly if MGA partnerships slow or underperform, or if climate driven catastrophe losses turn underwriting trends in the wrong direction.

Find out about the key risks to this SiriusPoint narrative.

Next Steps

With mixed sentiment around SiriusPoint’s valuation, underwriting track record, and MGA partnerships, move quickly to review both sides of the story for yourself, then weigh the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond SiriusPoint?

If SiriusPoint has you thinking more broadly about opportunities, do not stop here. Fresh ideas often come from comparing it with other strong contenders.

• Target consistent compounding by scanning companies built on resilient finances and steady operations through our 31 resilient stocks with low risk scores.
• Spot potential mispricing by reviewing businesses that pair solid fundamentals with attractive entry points inside the 20 high quality undiscovered gems.
• Strengthen your core holdings by filtering for robust cash positions and prudent leverage using the list of solid balance sheet and fundamentals (25 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com